| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.52 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |